医学
随机对照试验
复苏
败血症
随机化
优势比
临床终点
拯救脓毒症运动
临床试验
急诊医学
外科
内科学
感染性休克
严重败血症
作者
Alasdair Gray,Katherine Oatey,Julia Grahamslaw,S. Rodman Irvine,John Cafferkey,Titouan Kennel,John Norrie,Timothy Walsh,Nazir Lone,Daniel Horner,Andy Appelboam,Peter Hall,Richard J. E. Skipworth,Derek Bell,Kevin Rooney,Manu Shankar‐Hari,Alasdair Corfield
标识
DOI:10.1097/ccm.0000000000006348
摘要
International guidelines recommend IV crystalloid as the primary fluid for sepsis resuscitation, with 5% human albumin solution (HAS) as the second line. However, it is unclear which fluid has superior clinical effectiveness. We conducted a trial to assess the feasibility of delivering a randomized controlled trial comparing balanced crystalloid against 5% HAS as sole early resuscitation fluid in patients with sepsis presenting to hospital.
科研通智能强力驱动
Strongly Powered by AbleSci AI